USNEA UZARA XYSMALOBIUM UNDULATUM

USNEA (Usnea spp.) ++

Activities (Usnea) :
Analgesic (1; BGB); Antibacterial (1; FNF; WAM); Antiinflammatory (1; FNF); Antisarcomic (1; BGB); Antiseptic (2; BGB; KOM; PH2); Antitumor (1; BGB); Candidicide (1; BGB); Deodorant (1; BGB); Expectorant (f; BGB); Fungicide (1; BGB; WAM); Parasiticide (1; WAM).

Indications (Usnea) :
Bacteria (1; FNF; WAM); Boil (f; BGB); Bronchosis (f; BGB); Cancer (1; BGB; JLH); Candida (1; BGB); Cough (1; WAM); Cystosis (f; BGB); Fungus (1; BGB; WAM); Headache (f; BGB); Heatstroke (f; BGB); Infection (1; BGB; WAM); Inflammation (1; FNF; PH2); Lymphadenosis (f; BGB); Mucososis (2; HHB; KOM; PH2); Mycosis (1; BGB; WAM); Nephrosis (f; BGB); Pain (1; BGB); Parasite (1; WAM); Pharyngosis (2; KOM; PH2); Pleurosis (f; BGB); Scrofula (f; BGB); Sore (f; BGB); Sore Throat (f; BGB; PH2); Stomatosis (2; KOM; PH2); Strep Throat (f; BGB); Swelling (f; BGB; JLH); Tuberculosis (f; BGB; HHB); Tumor (1; BGB); UTI (f; BGB); Wart (f; JLH); Wound (f; BGB); Yeast (1; BGB).

Dosages (Usnea) :
1 lozenge (equivalent to 100 mg herb) 3–6 ×/day (KOM; PHR); 60 mg drug/day (PH2).

Contraindications, Interactions, and Side Effects (Usnea) :
None known (KOM; WAM). How’s this for a template, “Hazards and/or side effects not known for proper therapeutic dosages” (PH2). “Following overdosage, signs of poisoning could appear. These signs have yet to be described” (PHR; PH2).


UZARA (Xysmalobium undulatum (L.) R. Brown) +

Synonym :
Asclepias undulata L.

Activities (Uzara) :
Cardioactive (2; KOM; PIP); Digitalic (1; PH2); Motility Inhibitor (2; KOM; PIP).

Indications (Uzara) :
Diarrhea (2; KOM; PIP; PH2); Dysentery (f; PHR; PH2).

Dosages (Uzara) :
1 g drug (or equivalent of 75 mg total glycosides (KOM; PIP); 45–90 mg total glycosides (PH2); 45–90 mg uzarin/day (KOM; PIP).

Contraindications, Interactions, and Side Effects (Uzara) :
Not covered (AHP). Commission E reports for the root, no known side effects or interactions with other drugs; contraindicated with cardioactive glycosides. Consult a physician when diarrhea lasts for more than 3–4 days. Also reported to contain cardiac glycosides; has digitalis-like cardiac activity in higher doses (AEH). There have been fatalities following parenteral application of Uzara drugs (PHR).